tm
Seeing Is Believing
tm
Seeing Is Believing
CRVS is currently covered by 3 analysts with an average price target of $4.69. This is a potential upside of $3.25 (225.69%) from yesterday's end of day stock price of $1.44.
Corvus Pharmaceuticals's activity chart (see below) currently has 17 price targets and 20 ratings on display. The stock rating distribution of CRVS is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 46.63% with an average time for these price targets to be met of 158.67 days.
Highest price target for CRVS is $12, Lowest price target is $3.5, average price target is $4.69.
Most recent stock forecast was given by LI WATSEK from CANTOR FITZGERALD on 01-Apr-2024. First documented stock forecast 05-Apr-2017.
Currently out of the existing stock ratings of CRVS, 6 are a BUY (75%), 2 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
22 days ago
1/4 (25%)
$2.36 (143.90%)
45
Buy
12
$10.29 (601.75%)
10
9 months 13 days ago
1/3 (33.33%)
$9.03 (304.04%)
216
Hold
3.5
$1.79 (104.68%)
3.5
10 months 7 days ago
5/7 (71.43%)
$1.26 (56.25%)
302
Buy
8
$6.54 (447.95%)
2 years 4 months 21 days ago
0/1 (0%)
$4.69 (141.69%)
Buy
5
3 years 6 months 18 days ago
2/4 (50%)
$2.85 (132.56%)
313
What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?
Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?
